Orforglipron and Mitotane: Interaction Details

Brand names
Mitotane
Lysodren
Orforglipron
Foundayo
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Orforglipron With Mitotane

What can happen when they are taken together (rated Major)

Reduced orforglipron exposure and reduced of orforglipron

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Orforglipron should not be used together with strong , because these agents can lower orforglipron exposure and, in turn, may diminish its effectiveness. In drug interaction studies, giving orforglipron with carBAMazepine (a strong CYP3A4 ) at 300 mg twice daily lowered orforglipron by 82% and by 55%.1

The Orforglipron and Mitotane Interaction, Explained

Mitotane can make orforglipron work less well. Mitotane speeds up a liver enzyme () that breaks down orforglipron, so your body may clear the medicine faster and you may end up with lower levels. That could mean weaker help with blood sugar or weight control.

In a study, another strong enzyme-speeding drug (carbamazepine) cut orforglipron levels by more than 80%. Mitotane's effect has not been measured the same way, but the same mechanism is expected. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.

Mechanism: Mitotane is a strong . Orforglipron is cleared by CYP3A4-mediated , so is expected to decrease exposure and (PK interaction, not a scenario).

  • Magnitude: With carbamazepine 300 mg BID (strong CYP3A4 inducer), orforglipron fell 82% and 55%. Mitotane-specific data are not cited; the effect is inferred from the class.
  • Onset: Unspecified. Mitotane induction is typically prolonged and may persist after discontinuation.
  • Evidence: Probable.
  • Management: Avoid . If unavoidable, monitor glycemic and weight response closely and have the prescriber individualize therapy or consider alternatives.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Orforglipron and Mitotane Interact

The likely mechanism

of -mediated of orforglipron

In short: Mitotane speeds up CYP3A4, an enzyme that breaks down orforglipron, so orforglipron can be cleared faster.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Lowers Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Orforglipron and Mitotane Interaction

The documented advice is to avoid using these two medicines together, because lower orforglipron levels may reduce how well it works.

  • Keep taking both exactly as prescribed until your care team advises otherwise.
  • Tell your pharmacist and prescriber that you take both, so they can decide whether orforglipron is still the right choice or an alternative fits better.
  • If you stay on both, your team may monitor you more closely and individualize your treatment.
  • Report any loss of benefit, such as rising blood sugar readings or reduced appetite control.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Orforglipron or Mitotane need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: FOUNDAYO oral tablet, orforglipron oral tablet

    In drug interaction studies, of orforglipron with carBAMazepine (a strong ) at 300 mg twice daily lowered the of orforglipron by 82% and its by 55%.1

Orforglipron and Mitotane: Common Questions

How serious is the Orforglipron and Mitotane interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Orforglipron and Mitotane interaction managed?

The documented advice is to avoid using these two medicines together, because lower orforglipron levels may reduce how well it works. Keep taking both exactly as prescribed until your care team advises otherwise. Tell your pharmacist and prescriber that you take both, so they can decide whether orforglipron is still the right choice or an alternative fits better. If you stay on both, your team may… Management is individual — always follow your own care team's guidance.

Does taking Orforglipron and Mitotane at different times of day help?

No. Taking them at different times of day does not prevent this one. Mitotane speeds up , an enzyme that breaks down orforglipron, so orforglipron can be cleared faster. That change lasts while mitotane is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Orforglipron and Mitotane Interaction

Ask in your own words about taking Orforglipron and Mitotane together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: FOUNDAYO™ oral tablet, orforglipron oral tablet. Lilly USA LLC, Indianapolis, IN, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Orforglipron and Mitotane

Also serious with Mitotane

Also serious with Orforglipron

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Mitotane

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.